Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr Moro needs to develop point of care tests for monitoring with each current marker with the addition of recaf to boost their results. That would unbelievable! What management has been conveying is they are utilizing recaf in so many different ways and all have proven successful, so it is only a matter of time before recaf becomes an important utilized tool in modern medicine. Someone is squirming. Isn't it strange that Gaboy and I are limited to 1 post a day, and Mata a whopping 2 posts a day? Hmmmmmm?
IMO, Inverness will make a move and try and buy the company. Recaf just fits too perfectly in their arsenal of diagnostics. The fact that recaf can be used to monitor cancer, boosts current markers, is an inexpensive test, a POC test is on the horizon, and recently found additional indications in an untapped market by crossing over into veterinary medicine is just too compelling at these low levels. I just don't think Dr Moro will sell. (The recent stock options enabling management to buy shares at a 40% premium just last week has me thinking something is going on).
Did you notice the cost is between $500-600 for ova check?
Am I the only one that put 2 and 2 together with the last press release. Where did he get these blood samples? How did he measure their levels of circulating recaf BEFORE surgery and then AFTER surgery? Who now has Dr Moro convinced that recaf testing is a VERY VALUABLE tool in monitoring breast cancer since their is NO OTHER way to determine if the surgery was successful or the cancer has returned? Someone is party to these studies.
No matter what an anonymous basher says without holding a medical degree, he is dead wrong about the potential for recaf. I am not even putting RPC's product in the same category as recaf, because it has not been proven successful in every one of the ways that recaf has proven successful. There is NO test that is as versatile and can be detected in so many waysnas recaf. Also, there are no tests 100% perfect, but 90% + success would give you an A in school and just compare our results with every other FDA accepted marker being used today. We have precedents and I don't see the FDA denying us approval, on the contrary they will most likely be overjoyed.
Half, congratulations. I give your post #26794, post of the year. That is the most relevant example of how the process works, and gives Dr Moro a better idea of how to approach the FDA. Nice job.
Those type of posts are what brings me here. I also used Vermillion a while back as an example of what could transpire, and its effect on the share price due to the "special" nature of Dr Moro's discovery, however, the story behind its approval is fascinating and inspiring.
We need 2 major things to happen that will help the share price: 1)A new licensee 2)FDA approval. Then IMO Dr Moro should initiate a reverse split and IMMEDIATELY get us on a "normal" stock exchange. Until then we are, and will continue to be someone's prey. The OTC and the Pinks are the wild west like I said earlier and there are no regulations being enforced.
It is such old hat here. Whenever Biocurex puts out a press release then Gold has to spin it or demean it. Engaging a biased anonymous poster without a medical degree is a lost cause and a complete waste of time, but correcting misinformation by that individual has some merit.
I strongly concur with Dr Moro and his scientific board that using the receptor of AFP is a way to cure cancer. The problem is you cannot patent the receptor, only methods to direct an antibody to the receptor or a way to attach a molecule to the receptor. That is the holy grail, but to reach the holy grail, you must correctly identify the location of these cancerous cells, and that is precisely what Dr Moro has proved in so many ways. He has a way to find the cancer no matter the location or the stage of the cancer. A universal marker has tremendous value, because if Dr Moro can use an effective molecule that will be directed specifically to the cancer ANYWHERE in the body it is present, and not destroy or attach itself to healthy cells, he has effectively found a cure. I believe recaf will be utilized in this manner, but he must seperately patent the method to locate, deliver, and attach an antibody to that receptor.
IMO when he delivers on his promise of revenue the share price will move, otherwise it is futile when you have millions of shares outstanding and manipulators that will stair step it lower. The good news is that this will happen, regardless of the naysayers and the manipulators. GLTA
Combining markers makes recaf a serious contender. As a matter of fact, Dr Moro I had a genious idea this morning. Another application for recaf could be an autopsy. You identify the cause of death as cancer and combine recaf with existing markers to identify its location. Thank me later. Recaf is a useful tool and there no markers I heard of that are 100% accurate in both specificity and sensitivity. Cancer is extremely deadly, because you don't necessarily develop symtoms until it progresses, sometimes until it's already too late.
It's ironic that the most prolific poster on a cancer diagnotic company's board owns no stock in the company, and is someone without a medical degree. What's their motivation?
Another misstep I would like to share. Goldseeker wrote, "I did contact one of the Vets participating in the study. So far, not enough customers want to participate to draw any conclusions. A collection fee is charged by the vet which I thought was rather pricy. I did not ask but the fact they are charging for collection tells you that BioCurex is not paying for anything but the processing of the test."
First, how do YOU know how many samples were collected or how many vets participated? So how do YOU come to the conclusion that not enough participated to draw any conclusions? You were the one earlier tht said there was no study, right? Now you admit to the study, yet it is meaningless because there was not enough participation. Mr Goldseeker, where are the facts to come to your conclusion? So how do YOU draw THAT conclusion? Second, It was pricey, but you did not ask how much? Wow. I am not debating, just pointing out misinformation. IT DOES NOT ADD UP SIR.
Thanks for your confirmation, Gold. Here is what I wrote that was scoffed at, "I am strongly under the impression that all the collected samples are being used to show the merit of the test and the data collected IMO is being presented to interested parties (Vets as well as pharmaceutical companies) as Mata has proposed."
Gold fumbled again when he posted, "FYI, I have only found comments from 4 vets on the web mentioning oncopet. Three made actual comments. One just stated she was participating in a study for oncopet.
Here is what Gold's alter ego wrote, "What I now find amazing is the actual "flipping" of the whole Oncopet premise by some longs-ie- a product launch has now morphed into a "study".
I am a believer when I see with my own eyes all the buzz when I did a google search on Oncopet. The search included vets from across the US and Canada. There are hundreds, if not thousands more discussing Oncopet. Bottomline is word is spreading. IMO when Biocurex has licensed Oncopet our name will be associated with a pharmaceutical company that veterinarians are comfortable with, and the test will be utilized. Right now the skepticism is deserved, because we are an unfamiliar brand. Most are at the show me or prove it stage since it is not requiring FDA approval. Being a doctor myself that is the correct and understandable approach before bringing it into their practice. I am strongly under the impression that all the collected samples are being used to show the merit of the test and the data collected IMO is being presented to interested parties (Vets as well as pharmaceutical companies) as Mata has proposed.
I calmed down a little when I saw the amount of interested vets and the knowledge of the test raising curiosity among pet owners as well as doctors. For now I wish Dr Moro would explain to shareholders his intentions. Are we licensing the technology or is he going to do the testing and results in house? Is he going to do a 510K? (W/O the FDA approval recaf remains useless). IMO that was #1 on the list years ago. There is competition and patent expiration to worry about. As far as manipulation, when you trade on a bulsh@* exchange that trades like the wild west where the SEC could care less, you are are at the mercy of management to provide enough information to attract INVESTORS not day traders, by attending a variety of investor conferences and scientifc meetings, not just one or two a year. I am under the impression that we will get Oncopet licensed and it will give us much more credibility. IMO that is pretty much what this company HAS to do to become successful. If enough major parties are interested our name will get out there.
Regardless of Goldseeker's nonmedical point of view, which is all that it is, I see a much more positive reaction when I did my own search. Here is a few. I cannot understand Half still debating with someone that will NEVER admit when he is wrong. He is right only about one thing, he says I am not one of his fans. I'll give you that one. Here Gold, have some fun.
http://www.petconnection.com/blog/2010/04/15/can-a-simple-blood-test-diagnose-cancer-in-dogs/
http://locustvalleyvet.wordpress.com/2010/06/05/new-test-for-cancer-screening-in-animals/
http://www.doggedhealth.com/home/1791-recent-veterinary-breakthroughs.html?start=1
http://promega.wordpress.com/2010/05/12/an-early-detection-test-for-cancer-dogs-today-cats-tomorrow-soon-us/
http://petzmagazine.net/petzmagazine/noticias-mascotas/132-nuevo-analisis-para-detectar-cancer-en-los-perros.html
http://www.gopetplan.com/newsletter/201007/newsletter.aspx
http://www.caninek.org/Cancer.html
http://veterinarynews.dvm360.com/dvm/Veterinary+news/First-blood-test-unveiled-for-cancer-detection-in-/ArticleStandard/Article/detail/657623
http://www.wearethecure.org/index.php?mact=Search%2Ccntnt01%2Cdosearch%2C0&cntnt01returnid=15&cntnt01searchinput=oncopet
http://www.mypetcaretv.com/search-results.html?keywords=oncopet
Dr Moro, this is who you are doing business with.
http://www.thestreet.com/story/10613318/cel-sci-stock-promoter-has-troubled-sec-past.html
This individual did exactly the same thing to our company, but with us he promoted Biocurex while he cashed in over a million dollars while deteriorating our share price.
Gaboy, I get 1 post a day which is fine since there is no reason to continue locking horns with anonymous posters. You and I must have the same thoughts and sentiment toward the direction of this investment. I feel as though the share price is a report card on how management has been performing and delivering on their promises. Wouldn't you come to that conclusion? What I see is a 52 week low. The blame game is total bullsh@#. There are doers and there are talkers. In my life I am a doer, and that is what is eating me up. I never made excuses and had achieved success which has allowed me a blessed life. I am the type of person that would have contacted and met any person that would listen to what I have to say that could lead me and the company toward success. That said, I earned everything I have and I never, ever felt lucky, nor was born with a silver spoon in my mouth. I thought Dr Burger was the remedy since I had made the suggestion for several years that a seasoned biotech executive should run the company and Dr Moro concentrate soley on the science. I'm not sure what that has done for us at this point since I don't see any promises being delivered.
On the bright side, yesterday I googled oncopet (which would be a great suggestion for any investors still hanging on) and, I came across hundreds of articles expressing their excitement and others with concerns. For the most part a majority of the articles were very positive. That gave me a better feeling toward what MIGHT be happening at home base. There were none that I found that did not feel this test was a total bust. The most common response was that it was a revolutionary test in veterinary medicine that could be used as an important tool to monitor cancer, rule out cancer, or to see if treatment is having a positive response. I am animal lover myself, and there is definitely something innocent and pure when you receive and feel their love. It is always unconditional. That love requires only that you care for your pet as you would any family member. That said, oncopet will be successful in that manner. IMO, it won't be a random test that every pet owner will be asked by their vet to perform, but it will be used to monitor treatment. The good news is that this is the first test of its kind in veterinary medicine which has huge implications, and second, this test can be marketed worldwide.
I have read articles from independent doctors that claim they are excited of our product and they are part of a huge study being performed by Biocurex. What must be happening since no one is communicating to shareholders is that Biocurex must be performing their own study to use these results to sell the rights to a pharmaceutical company that deals directly with veterinary clinics across the US and outside the US. That is why Dr Moro is hush hush and he has not reported any income. He does not want to continue doing the testing in house, but sell the rights to the product. He keeps commenting on the human recaf as his real objective. Being in research his whole life this is the only thing he knows. Come up with a logical hypothesis, test that hypothesis, study the results, then tweek the test to arrive at the best outcome achievable. The problem with this the time consumed to get from A to B. Anyone who owns a business knows an important rule and that is time is money. That is why biotech is the toughest investment, but it can be the most rewarding.
I want everyone to know that this investment has been emotional and costly to me personally. I don't think we need to panic or assume recaf will not be successful, quite the contrary. We have all experienced some near disasters that turned out very well, but I have to say that my personality is such that I hate not knowing what they are up to with MY money. The best thing possible is they license out oncopet and work on the 510k. That is what I want to see them accomplish THIS SUMMER. I'm getting ready for this evening's festivities, so I'll turn it over to Goldseeker who I'm sure has much to say. Happy Independence Day to all (sadly, it may be renamed in the US as Dependence Day).
I don't understand why Dr Moro never submitted for the 510k. I thought when Dr Burger and Dr Walsh joined the company and they raised millions of dollars that things would change. So far, I have no indication that this has changed anything. If anything, it is much worse as far as communication with shareholders. The 52 week low says it all. You can't blame the markets when we never saw any stock price appreciation EVER. Disappointment is an understatement. It has nothing to do with anonymous posters bashing the company. Everyone is clear that there is only one reason someone would manically post and claim to own no shares, however, that topic deserves no more time mentioning. I am posting, because if Dr Moro reads this board he needs to know that his lack of communication has ALWAYS been his downfall and has cost loyal shareholders HUGE financial loses. When I saw RPC, a competitor, get new management and rallied their company's stock from .20 to 2.59 it reassured me that we would follow suit. However, that is not what has happened and I nor anyone else have any inkling as to what is happening WHATSOEVER at the company. (Goldseeker will use this post and make his remarks, but whatever his commentary I consider it quite innocuous). It is not unlawful to have a press release announcing you are in discussions for licensing or selling a portion or all of the company if this is what is transpiring. You need to do something to reassure your shareholders or it may be too little too late.
Just got a press release for S8. Issuing stock options of 28,500,000 shares
Owned on Percent
Selling Number of Number of Shares Completion of of
Shareholder Shares Owned Being Offered (1) Offering Class
----------- ------------ ----------------- -------------- --------
Dr. Ricardo Moro 1,100,000 15,000,000 1,100,000 .56
Denis Burger 1,557,286 10,000,000 1,557,286 .80
Phil Gold 175,000 1,000,000 175,000 .09
Antonia Bold de Haughton -- 1,000,000 -- --
Jim Walsh 714,286 1,000,000 714,286 .37
Gladys Chan -- 500,000 -- --
-----------
28,500,000
===========
(1) Represents shares issuable upon the exercise of stock options. Each option
is exercisable at a price of $0.0714 and expires on January 22, 2020.
_____________________________________________________________________
Is this a good thing considering options are excersizable @.0714 and they plan on being in business till 2020? Dilution, yes. I'm numb at this point. I already know Gold's take on this.
Anyone have a tourniquet?
After doing more due diligence I found out GTC orders are worthless to thwart any short sales. What I did find out is that most us have margin accounts and those stocks listed as being bought in a margin account are available to be borrowed to sell short. The only way to protect your BOCX shares from being "borrowed" for the scumbags to short is if: 1) You put your shares in a cash account. 2) They can't "borrow" shares from an IRA account.
Use this information. Those are the facts.
Time to account for the stock certificates. Everyone needs to put in a GTC order for a much higher price, so those shares could not be "borrowed" to short. This goes beyond manipulation. If you watched the video I posted you see EXACTLY how this fraud is perpetrated. Justice needs to be served. IMO Dr Moro is well aware of this, but for some reason will not expend the energy to combat it. If I were CEO and had my life's work on the line I would take action. No one is selling, so if the scumbags that have done this for profit are backed into a corner THEY HAVE TO COVER. In an illiquid stock, the tables would be turned and they are the ones losing all of their ill-gotten gains.
Find a way to reissue the certificates and call them all in. We just officially named the company Biocurex. Call it Biocurex International and recall the certificates so you could issue new ones and wellah. Problem solved. Let's see if mangement truly cares about their shareholders. Get creative, but fix it!
By management keeping quiet, it dries up any buying which causes no demand for stock which in turn leads to oversupply of shares and this video (link below) explains how individuals have been taking advantage of this fact, and is why BOCX is at .05 cents. I have posted a link for a video which reveals exactly what Mata has been harping on for months. However, for me, the real takeaway is that management are their own worst enemy by repeating the same mistakes by failing to communicate with their shareholders. Please take the time to view this audio slideshow. It is very insightful. Other than maybe one piece of useful information that appears once in a blue moon the conversations here IMO, cause cerebral hypoxia. Enjoy the video, although you may end up disgusted, as is the case with me. GLTA (Just keeping it real).
http://www.businessjive.com/ Please do me a favor, and let me know what you guys think after watching. Also, you will be in shock if you listen to at least half of the video. It explains alot! If management asks shareholders to account for and report all stock certificates we could break this cartel and put some people in jail.
Half, why persist on debating. He was wrong with RPC. He will be wrong with BOCX. RPC is a top ten penny stock for 2010. My focus is on what BOCX is doing with my money. Alot of promises have been made. I'll leave it at that. Manipulation is part of the game. Especially if the company appears weak even though there is alot of favorable things transpiring behind the scenes that are not revealed to its shareholders. In my mind I thought we would have heard something by now. Dr Burger should be at more investor conferences and Dr Moro at more scientific conferences. Not much selling or buying, just holding and waiting. Mata?
Radient (RPC) is a company that proves that given proper management an resources a turnaround is achievable. The big difference is THEY COMMUNICATE WITH THEIR SHAREHOLDERS.
Mata, it's time for a conference call for shareholders. It seems to working for RPC. Look at their YTD return. Very frustrating for BOCX shareholders to put it mildly. http://www.thestreet.com/quote/RPC.html (under the headline of Top 10 Penny Stocks of 2010). You know I am mentioning RPC, because of the comparisons. The latest penny rag (which I openly detest and consider a waste of money) promotes Biocurex and is touting a buyout. Is that on the table?
Mata, in your opinion why won't Dr Moro collaborate with Constab? Very frustrating. I know he is in his bubble, but I spoke with him 6 years ago and my first comment was that it would be a foot race to the finish. As my name suggests, opportunity is knocking. It would also be nice to know if he is in clinical trials on his own. Personally, I feel no one cares about the comments about the churning. What I care about is what is happening at the company. I felt in the past I would get useful information here, but for the last year it has become a complete waste of time. The same bickering and bantering. An update is in order.
Free money:
Tucked away on page 759 of the voluminous health-care law signed by
President Barack Obama in March is a provision to aid small companies
doing research and development (R&D) in biotechnology. Starting on 21
June, many of those companies will be racing to take advantage of a
tax credit worth up to $5 million per company and totalling $1
billion.
Called the Therapeutic Discovery Project Program, the initiative aims
to lift an industry that has struggled during the recent economic
crisis. When anxious investors shifted money to low-risk investments,
high-risk biopharmaceutical companies, particularly young firms with
no products on the market, were left scrambling for cash (see graph).
The pressure has taken its toll. According to the Biotechnology
Industry Organization (BIO), there were at least 394 public US biotech
firms in January 2008. By January 2010, 285 remained. Most of those
lost were early-stage firms. "We were seeing literally a generation of
biotech companies being shelved," says Alan Eisenberg, BIO's vice-
president for emerging companies and business development.
The tax credit is targeted at vulnerable young businesses — only those
with fewer than 250 employees are eligible — and covers up to half of
the R&D expense for qualifying projects. Because most biotech
companies don't earn a profit in their early years, and therefore owe
no taxes, they wouldn't benefit from a tax credit. So the programme
allows those firms to convert the credits into grants. In fact, the
programme is largely a grants programme disguised as a tax credit,
says Barry Bozeman, a professor of public policy at the University of
Georgia in Athens, who notes that tax credits tend to be more
politically palatable.
To be eligible, a project must demonstrate the potential to produce
new therapies, reduce the cost of health care or contribute to the
goal of curing cancer within 30 years.
Under the programme there is no limit to the number of projects that
can be funded at a single company, and the $1 billion total will be
distributed among all qualifying projects. Eisenberg estimates that
about 600 of BIO's members will apply for funds, plus about 600
companies that are not part of the organization. This deluge of
applications could lead to smaller awards per proposal. "In all
likelihood, with so many applications, no project is going to get more
than a million dollars," says Kurland. Eisenberg points out that 85%
of BIO's members with fewer than 350 employees have R&D budgets of
less than $30 million.
The grants are clearly tiny compared with the billions often required
to fully develop a new drug, but they are enough to stimulate early-
stage research, says Eisenberg. "Will it mean that you don't have to
go out and do other fundraising?" says Kurland. "No. But maybe it gets
you over the hump, or maybe it encourages others to invest in your
company."
The credit should help address concerns that US biotechnology is
falling behind in the face of increasingly vigorous international
competition. "The United States was the first to have a tax credit for
R&D back in 1981," says Gregory Tassey, a senior economist at the
National Institute of Standards and Technology in Gaithersburg. "Since
then, other countries have come up with their own. Now we're down
around seventeenth in terms of actual financial impact of our R&D
credit."
For now, the credit is only mandated to cover costs incurred in 2009
and 2010, but it's a safe bet that the industry will lobby for the
programme's renewal. Even so, the credit is unlikely to solve the real
challenge facing the sector: how to sustain a high-risk industry that
often takes a decade or longer to generate a viable product.
From all of the 26539 messages posted here anonymously, there is only 1 post that is relevant to what is happening at Biocurex.
"The personalization aspect of the test is huge. Any developing cancer will cause your RECAF level to dramatically increase. It detects the level of cancer cell division so any change in your normal level is a RED ALERT. Researchers are developing treatments that use the same technology so it does not really matter where the cancer is."
quote from............. GOLDSEEKER!!!!!!!!!!!
Brilliant deduction and it is the exact reason for investors to be patient. This is the biotech space and things take time. In between press releases speculation always runs wild. Only advice is to remember why you were excited about Biocurex and you will have the fortitude to hang on and in time you will be proven correct.
I would say that since the IPO a solid majority of investors (other than the churning to create the illusion of liquidity) realize the potential and are patient, because as Mata stated, "there's no drama concerning veterinary use for recaf. the company is going to license veterinary use. the only difference between recaf for humans and animals is the blood being tested and the resulting statistical modeling.
they need blood samples and this is rather an ingenious and cheap way to validate the science in order to license it.
bocxfans. look for the next license agreement and wait for inverness.
the science has been perfected and it works."
"the science has been perfected and it works.
be patient and do your own dew diligence."
Sounds like the sharks will soon be the prey. I have the same scenario investing in stem cell therapy, but the science works and patience will be rewarded. One unschooled individual is so wrong and will have wasted years of ranting. No reason to discuss the science with someone that has zero background in medicine. It's futile.
"mr. mata. i think good news is coming. inverness is going to use recaf for monitoring...takes time. more validation is on the way and more license agreements"
I hope your right
Half let him rant. RPC (Radient pharmaceuticals previously known as AMDL) is up today over 68% on 10 million shares traded. We are on the right path. We will have a rapid test soon and we have licenses with Abbott and Inverness and I'll bet Dr Moro is working on FDA approval. For goodness sakes stop feeding him. It's ridiculous. I'm not even reading any posts, but noticed it's just you 2 duking it out after YEARS of the same arguments.
WTF Goldseeker! You just stated, "There is no way that anyone will allow an actual cancer, slow growing, dormant or whatever to exist."
That statement is exactly the opposite to your illogical reasoning for not conceding that recaf will be an extremely useful tool in modern medicine. That now speaks in favor of recaf.
I have no reason to argue with your OPINIONS or spend another minute here, but today was historic not only for the markets in general, but that statement had to be a huge MISSTEP on your part. Thanks, I needed to be cheered up after today's action in the markets. Read it again, your now on our side once again. LOL
Tomorrow we present at the BIGGEST Biotech meeting with ALL of the "big" boys. Adds huge credibility. Nice surprise. Management is beginning to formulate a solid foundation for growth. Can't ask for more if you believe in the technology. Now here comes the derogatory comments toward my post. Patience is a virtue. GLTA
Investors of BOCX, where there is smoke there is fire! RPC a similar biotech company that has had their DR-70 universal cancer marker compared to recaf has been resurrected. I hope Dr Moro is watching this closely. Look beyond the US borders. Do whatever it takes.
Here is an article from "Seeking Alpha," posted today about Radient Pharmaceuticals (previously AMDL) and please note their projected earnings..............................................
"Speaking of Radient Pharmaceuticals, we're told the company raised about $6 million dollars during their recent price run. The first half of the six million was raised at roughly $.40 per share and the second half at about $1.30 per share (roughly 6 million warrants at each of the price points).
Investors shorted heavily versus these 12 million shares and it appears many of them have been the source of the selling in the past few days. Most or all of this shorting is also naked since no one can find enough shares to borrow.
The simple equation means that a fully diluted share count would equal 34 million shares plus approximately 12 million warrants. That's where things are going to stay, versus 87 million shares if the company's debt had been converted. It now has all the funds it needs (roughly $10 million more in cash) to go cash flow positive in the third quarter and because of that, shareholders are not willing to let the debt convert in such an unfavorable fashion.
If the company makes the forecasted $3 million in earnings without any help from it's Chinese Pharma operations, then they are looking at +$.10 per share this year.
If RPC makes $30 million in sales next year, then you're looking at somewhere between $.50 and $.70 per share next year.
That's enough for fund managers and analysts to put shares at well over $5 per share with a 10x multiple on it for future discount- and that does NOT include the value of the company's Chinese Pharma asset. If you added that asset - which, again, is being looked at as an acquisition target by at least one publicly traded company - then that's an easy $25+ million or $.75 per share.
The sentiment is that the naked shorts (as many as 20 million shares worth) will start to feel a burning sensation as early as today. We'll see how long they can hold out before they have to start covering.
If that was all too complicated, then here is the Cliff's Notes version for you:
RPC = Still Greatly Undervalued (especially if the cancer test is as good as the peer-reviewed journal articles are saying it is).
http://finance.yahoo.com/q?s=RPC
..................................................................
<LOOK DR MORO OR DR BERGER AT THIS RECENT DEVELOPMENT>
NOW WE HAVE A BUSINESS MODEL AND A BLUEPRINT ON HOW TO GET US NOTICED AND GET THE SHARE PRICE ABOVE A DOLLAR. IF THEY CAN DO IT, WE CERTAINLY CAN!!! TIME TO GATHER UP THOSE IRONS IN THE FIRE AND MAKE IT HAPPEN!!! I WOULD ALSO SAY IT'S TIME TO REPAY YOUR LOYAL SHAREHOLDERS!!!
Interesting development. Undeniable VALIDATION. Another precedent. Now is Inverness stupid? Are BOCX investors stupid? No. We are patient and realize there will always be hurdles when dealing with beaurocracy. Does RPC have a rapid test under development? The writing is on the wall people.
Things are definitely heating up. The more bs that is being spewed the more iodiotic the only remaining naysayer will appear in the upcoming near future. Nice to be in the loop.....You got that right. In reality there is really only one person out of the loop, someone that is very concerned at the success of our baby biotech. We have funds coming in, royalties due this year, a new licensee, more products being developed and launched, expanding internationally, cash for 3 more years......life is good!!!(at least for some of us)
------------------------------------------------------------------------
Disclaimer: I don't claim to know anything I am talking about nor does anyone else. This website is for people with too much time on their hands. Use at your own risk.
Disclaimer time again. LOL What a joke!!!!
Taking into consideration that there are 100 million visits from new patients each year, we estimate a potential market size for RECAF "point-of-care" tests of 50 million determinations per year in the U.S.A. alone. The European Union and Japan combined have twice the population of the U.S.A. and therefore it is safe to assume that they represent another 100 million tests. Given the low cost of the test and the possibility that it might be the only RECAF test affordable in many regions, it seems reasonable to allocate another 50 million tests to China, India and the rest of the world. Assuming a price of $5 per test, the estimated potential market would therefore be approximately $1 billion per year.
Ka-ching. It's coming.
Dr Burger has admitted he basically came out of retirement, because he was just too enticed with the potential to change the healthcare system with recaf. He and Dr Walsh both put their own money where their mouth is, and that is what every investor wants to see and is a sign of confidence from management. The conference call was significant in that it is emblematic of a change in the way management will communicate with shareholders, and it represents a giant effort to make it known that management is well aware of its obligation to shareholders. I was impressed to see that shareholders were free to ask questions which took up most of the time alotted. Dr Burger has added alot of legitimacy since he has taken the reigns.
The next important thing to happen in the next few weeks is the new Biocurex website. It was something many of us were asking of Dr Moro. I like the oncopetdiagnostics website, but I am hoping for something much more elaborate since it is our storefront. I am curious about us being a Canadian company on an American stock exchange and our taxes when revenue exceeds expenses in the next 18 months or sooner.
Needprofit, I see you like to speculate. Do you own any stem cell companies?
Somone is maxxing out their posting privelges Just a sample from the past 3 days
Short Interest % Change Avg. Daily Share Volume BioCurex (BOCX)
2/25/2010 1:23:09 PM
Buy volume ZERO, Sell volume 100,000 BioCurex (BOCX)
2/25/2010 1:17:49 PM
Burger stated they were going to be running BioCurex (BOCX)
2/25/2010 12:08:36 PM
The following is from the MacroArray website and BioCurex (BOCX)
2/25/2010 10:56:19 AM
Burger''s statement about Abbott in the conference call BioCurex (BOCX)
2/25/2010 10:21:50 AM
NeedProfit, just pointing out that what Burger attempt BioCurex (BOCX)
2/25/2010 9:38:59 AM
Two of Epitope Inc.''s Founders, Its Chairman And BioCurex (BOCX)
2/24/2010 6:18:25 PM
PORTLAND, Ore.--(BUSINESS WIRE)--Jan. 30, 2003 BioCurex (BOCX)
2/24/2010 6:10:05 PM
Opportunity, you are a moderator of this board. BioCurex (BOCX)
2/24/2010 1:44:27 PM
needProfit, getting a POC cancer device developed is BioCurex (BOCX)
2/24/2010 12:55:50 PM
The FDA is not going to approve any BioCurex (BOCX)
2/24/2010 12:28:34 PM
The Triage by Inverness is a POC device BioCurex (BOCX)
2/24/2010 12:17:51 PM
You stated: "What is the fatal flaw of BioCurex (BOCX)
2/24/2010 12:02:06 PM
Mitcheroo, The question was asked about getting bocx BioCurex (BOCX)
2/24/2010 11:47:36 AM
You stated: "All I have come up with BioCurex (BOCX)
2/24/2010 11:21:39 AM
Well, the conference call has also failed to BioCurex (BOCX)
2/24/2010 10:15:13 AM
Burger talked about Moro meeting with a few BioCurex (BOCX)
2/24/2010 10:07:39 AM
It is time to look at the big BioCurex (BOCX)
2/24/2010 9:59:47 AM
For those of you who emailed me for BioCurex (BOCX)
2/24/2010 8:07:24 AM
Burger stated that BioCurex would use $2 million BioCurex (BOCX)
2/24/2010 8:02:44 AM
Opportunity, Burger is making a fairly complicated process BioCurex (BOCX)
2/23/2010 9:22:45 PM
Bob, Dog RECAF is NOT an RIA test. BioCurex (BOCX)
2/23/2010 8:55:25 PM
Duke, the warrants do not automatically get called BioCurex (BOCX)
2/23/2010 8:52:02 PM
bob, if they make a lot of money BioCurex (BOCX)
2/23/2010 7:14:15 PM
The replay phone number,
(800) 642-1687 or (706) BioCurex (BOCX)
2/23/2010 7:09:53 PM
Burger also stated that he would address the BioCurex (BOCX)
2/23/2010 6:59:29 PM
Burger said the test addressed a billion dollar BioCurex (BOCX)
2/23/2010 6:48:26 PM
No Duke, nothing new. He was cautious about BioCurex (BOCX)
2/23/2010 6:40:01 PM
One point where Burger was in total error. BioCurex (BOCX)
2/23/2010 6:27:57 PM
Bob, Burger called it a "stock consolidation" to BioCurex (BOCX)
2/23/2010 6:24:11 PM
Erthang stated: "To date, I haven''t lost a BioCurex (BOCX)
2/23/2010 1:27:24 PM
Gaboy, I understand that you never believe anything BioCurex (BOCX)
2/23/2010 1:17:26 PM
Wow, 10 minutes past opening and no dumping BioCurex (BOCX)
2/23/2010 9:40:56 AM
Gaboy, BioCurex is still on the "failure to BioCurex (BOCX)
2/23/2010 9:36:05 AM
NeedProfit stated: "Bocx is a new company now BioCurex (BOCX)
2/23/2010 7:17:56 AM
NeedProfit stated: "I am psyched. I agree that BioCurex (BOCX)
2/22/2010 10:24:19 PM
Arnold, There is just a huge difference of BioCurex (BOCX)
2/22/2010 8:47:25 PM
Half, just as I predicted that he would BioCurex (BOCX)
2/22/2010 8:04:24 PM
Half, you complain about my posts but you BioCurex (BOCX)
2/22/2010 7:27:33 PM
After a volume of over a million shares BioCurex (BOCX)
2/22/2010 7:12:53 PM
nuthinbut, I have no financial interest in this BioCurex (BOCX)
2/22/2010 2:30:11 PM
Gaboy, I find the stock story interesting to BioCurex (BOCX)
2/22/2010 2:18:38 PM
Half, If you think I have violated any BioCurex (BOCX)
2/22/2010 12:57:33 PM
"Gold, It is a shame that the public BioCurex (BOCX)
2/22/2010 12:46:58 PM
Topics of discussion on the call will include BioCurex (BOCX)
2/22/2010 12:14:52 PM
There is no such thing as a seller BioCurex (BOCX)
2/22/2010 11:25:41 AM
What should be remembered from Half Full is BioCurex (BOCX)
2/21/2010 2:16:48 PM
Half, since I do not trade or have BioCurex (BOCX)
2/21/2010 12:33:32 PM
As of today, the stock is still on BioCurex (BOCX)
2/21/2010 12:16:35 PM
No Half, it is Moro that is not BioCurex (BOCX)
2/21/2010 11:16:58 AM
Just listened to the conference call. My only comment is.......Abbott, you better get out your freakin' checkbook, cuz there's a new sheriff in town!
Anyone that invested in Biocurex that fails to realize the potential of PAIRING recaf with current markers to eliminate all uncertainty or put another way, the elimination of all false positives (pairing of Dr Gold's PSA marker, or CEA colorectal cancer, and the CA-125 ovarian cancer) and responds to anonymous posters that are self-proclaimed gurus of all fields of medicine, the FDA, international law, the SEC, and mindreading does NOT deserve to be in this stock. The manipulation and negativity is so apparently obvious, it has been a running joke on this website for many months. If you listen to him much longer, you may be afraid to leave your house like him, because you may be hit by a meteorite.
Did you ever ask yourself why this anonymous poster NEVER EVER will talk about the pairing of recaf with current markers and why he continues the comparison of other universal markers that cannot show evidence of this? Maybe because he will have to concede recaf has great potential in modern medicine in so many different ways. Hmmmmm.
This is a new company when Dr Burger to the helm. Credibility and experience will open many doors. The response is always the same. Nothing. He will never acknowledge the presentation in front of an INTERNATIONAL congress of scientists that are oncologists. I guess Dr Moro made the whole thing up. This is despicable and sad how an anonymous poster tries to discredit Biocurex and what it stands for. What a piece of work!
Duke, glad to hear you are in good health.
Needprofit, I agree that having both Dr Burger and Dr Walsh are what's making shareholders confident. Both doctors see tremendous potential for many applications of recaf. They would never stick their heads on the chopping block and risk their reputations or their own money on Biocurex if they were uncertain. The timelines seem reasonable and attainable. We have lots of cash and good to go for at least 3 years. What a difference a few months make. Looking forward to a new polished more modern website. Sounds like they are inviting vets in the area to come to Biocurex and see hands on how doggy recaf works. I would like Biocurex to put out a video on youtube to demonstrate recaf to vets as a reference and for pet owners as well. Free publicity and free marketing.
IMO the conference call (which I missed unfortunatey) was a gesture to shareholders to let them know how hard they are working and will continue to work for shareholders to capitalize on the full potential of recaf. Dr Burger orchestrated the IPO, and if no one took notice how well the IPO was received they don't truly know what a HUGE asset Dr Burger is to Dr Moro and to shareholders. Between Dr Burger and Dr Walsh we have access to a rolodex of potential licensees and distributors. Dr Burger has successfully directed this movie many times before, and that knowledge along with his worldwide contacts will take us into new territory.
Today was an important step to prove this IS a new company and their focus is on bringing together with all their resources the full potential of recaf in a regimented, timely fashion with realistic goals.
They are accomplishing everything I was harping about for years. It's awesome. Getting a seasoned biotech executive to run the company, having conference calls with Q and A for shareholders, a new website for the company, and working toward getting on a more senior stock exchange. My final request is that we see Dr Moro at MANY more scientific meetings and Dr Burger at MANY more investor conferences. All in all it's been a long time coming. The training wheels came off today. I'll be watching for that 510k application on the FDA website.
Money gives you the power to do things you could not before. Strong leadership gives you the ability to accomplish your goals. Experience gives you the credibility required. Mistakes are an important part of the process, and as long as you can get back up and use it as a lesson and a learning experience, it will only make you want it more. Dr Burger states that recaf will change medicine and help all mankind. That mindset alone will open doors we have not entered previously. Recaf has been verified independently, so I believe another partner will happen as promised. I will no longer comment or respond to anonymous posters. It is demeaning. There will be alot of discussion after the conference call. Don't feel compelled to respond to illogical comments. There is only 1 anonymous basher left. Even his old compadres are rubbing salt in his wounds for not conceding.
Success is the best revenge.